Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor |
Globe Newswire |
11/14 |
07:01 |
Reed’s Reports Third Quarter 2024 Results and Provides Business Update |
Globe Newswire |
11/14 |
07:00 |
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates |
Globe Newswire |
11/14 |
07:00 |
TransAlta to Acquire Heartland Generation from Energy Capital Partners at a Reduced Price of $542 Million |
Globe Newswire |
11/14 |
07:00 |
Top Federal Reserve official defends central bank's independence in wake of Trump win |
AP Online |
11/14 |
07:00 |
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting |
Globe Newswire |
11/14 |
07:00 |
The Open Source Initiative and the Eclipse Foundation to Collaborate on Shaping Open Source AI (OSAI) Public Policy |
Globe Newswire |
11/14 |
07:00 |
Telesat Reports Results for the Quarter and Nine Months Ended September 30, 2024 |
Globe Newswire |
11/14 |
07:00 |
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/14 |
07:00 |
OneWater Marine Inc. Announces Fiscal Fourth Quarter and Full-Year 2024 Results |
Globe Newswire |
11/14 |
07:00 |
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease |
Globe Newswire |
11/14 |
07:00 |
The Future of AI PC: Market Segmentation, Growth Projections, Opportunities and Forecast to 2030 |
Globe Newswire |
11/14 |
07:00 |
Boralex reports operating income of $7 million and actively pursues its development and diversification activities in the third quarter |
Globe Newswire |
11/14 |
07:00 |
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update |
Globe Newswire |
11/14 |
07:00 |
Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola |
Globe Newswire |
11/14 |
07:00 |
Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
11/14 |
07:00 |
FlexShopper, Inc. Reports Record 2024 Third-Quarter Financial Results |
Globe Newswire |
11/14 |
07:00 |
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor |
Globe Newswire |
11/14 |
07:00 |
Singing Machine and Stingray Announce Karaoke Microphone Partnership with BYD |
Globe Newswire |
11/14 |
07:00 |
Bread Financial Provides Performance Update for October 2024 |
Globe Newswire |
11/14 |
07:00 |
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer |
Globe Newswire |
11/14 |
07:00 |
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights |
Globe Newswire |
11/14 |
07:00 |
Car Fuel Filter Market is Predicted to Reach US$ 3.05 Billion with Expanding at a CAGR of 5.8% by 2034 | Fact.MR Report |
Globe Newswire |
11/14 |
07:00 |
Innventure Reports Third Quarter 2024 Results |
Globe Newswire |
11/14 |
07:00 |
Ashland board authorizes quarterly dividend |
Globe Newswire |
11/14 |
07:00 |